FDA 483 - GSK Vaccines GmbH - November 12, 2024
FDA 483 for GSK Vaccines GmbH on November 12, 2024. Product: Biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for GSK Vaccines GmbH on November 12, 2024. Product: Biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
GSK Vaccines GmbHInspection Date
November 12, 2024
Product Type
Biologics
ID: b101b4d2-e2cb-4f6d-b47c-fbd0d1013735
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox